Skip to main content

Advertisement

Table 5 Unadjusted and adjusted models of adherence-related predictors of SVR among the study population

From: Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

  SVR (%) Unadjusted OR 95% CI P Adjusted OR 95% CI P
95% ribavirin adherence*
 No 17 (63) 1.00 - - - - -
 Yes 44 (73) 1.62 0.61–4.26 0.330 - - -
100% PEG-IFN adherence*
 No 58 (67) 1.00 - - - - -
 Yes 3 (50) 2.00 0.38–10.53 0.413 - - -
Completed therapy
 No 2 (9) 1.00 - - 1.00 - -
 Yes 59 (83) 34.41 6.90–171.55 0.000 23.86 2.94–193.84 0.003
  1. The adjusted model is adjusted for all factors associated with SVR from the primary analysis [11]
  2. *On-treatment adherence